Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Help & FAQ
Link opens in a new tab
Search content at Houston Methodist Scholars
Home
Experts
Research units
Research output
Prizes
View Scopus Profile
Yong Lu, PhD
Associate Professor of Immunology in Medicine
,
Academic Institute
Member, Research Institute
,
Academic Institute
Charles W. Duncan Jr. Department of Medicine
Dr. Mary and Ron Neal Cancer Center
Houston Methodist
Weill Cornell Medical College
Email
ylu2
houstonmethodist
org
h-index
2581
Citations
28
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2012
2026
Research activity per year
Overview
Fingerprint
Network
Research output
(52)
Prizes
(3)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Yong Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Myeloma
90%
Multiple Myeloma
88%
Myeloma Cells
79%
Tumor Cells
66%
Th9 Cells
63%
Tumor-specific
57%
Tumor Immunity
56%
Cancer Immunotherapy
54%
T Cells
54%
Tumor
46%
Dendritic Cells
43%
Chimeric Antigen Receptor T Cells (CAR-T)
35%
IL-9
30%
Solid Tumors
29%
CAR T-cell Therapy
28%
Immune Evasion
28%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
28%
Immune Checkpoint Blockade
26%
In Cancer
25%
Monoclonal Antibody
23%
Macrophages
23%
Bone Marrow
23%
Antitumor Immune Response
22%
Cell-derived
21%
Adoptive Cell Therapy
20%
Interleukin-9
20%
CD4+ T Cells
20%
Drug Resistance
20%
Programmed Death-ligand 1 (PD-L1)
20%
T Cell Response
19%
Monocyte Chemoattractant protein-1 (MCP-1)
19%
Tumor Growth
19%
LILRB3
19%
Idiotype
19%
Antigen Loss
19%
Acquired Resistance
19%
Dickkopf-1 (DKK1)
19%
Leukemia Progression
19%
Immunosuppressive Cells
19%
Mantle Cell Lymphoma
19%
Acute Myeloid Leukemia
19%
CD8+ T Cells
18%
Induced Apoptosis
18%
Advanced Tumor
16%
Interferon-α (IFN-α)
15%
Osteoclast
15%
Leukemia
14%
Cancer Cells
14%
Tumor-specific T Cells
14%
Antitumor
14%
Immunology and Microbiology
Multiple Myeloma
100%
Myeloma Cell
87%
T Cell
81%
Immune Response
50%
Immunotherapy
49%
Tumor Cell
47%
Cancer Immunotherapy
45%
Th9 Cell
45%
Dendritic Cell
40%
Cytotoxic T-Cell
37%
In Vitro
32%
CD8
31%
Chimeric Antigen Receptor T-Cell
31%
Macrophage
30%
Tumor Immunity
28%
Osteoclast
24%
Immunosuppression
23%
T-Helper Cell
22%
Drug Resistance
22%
Monoclonal Antibody
20%
Interleukin 9
20%
Programmed Cell Death
20%
CD4
20%
Cytokine
19%
Idiotype
19%
Immune Evasion
19%
Myeloid
19%
Cell Differentiation
18%
Immunosuppressive Drug
17%
Cancer Cell
17%
Osteoblast
15%
Osteoclastogenesis
15%
Chimeric Antigen Receptor
15%
Agonist
14%
Regulatory T Cell
14%
Dynamics
14%
Mouse Model
13%
Tumor Antigen
13%
Programmed Death-Ligand 1
12%
RANK
11%
Western Blot
11%
Immune Checkpoint Blockade
11%
Interferon
11%
Cell Death
11%
Immune Escape
11%
RNA Sequencing
11%
Cell Survival
11%
B Cell
10%
Mitogen
10%
Dexamethasone
10%
Medicine and Dentistry
Tumor
64%
Tumor Cell
54%
Multiple Myeloma
47%
Myeloma Cell
47%
Neoplasm
45%
T Cell
38%
Specific Tumor
35%
Th9 Cell
33%
Immunotherapy
32%
Myeloma
29%
Dendritic Cell
29%
Immune Evasion
28%
Chimeric Antigen Receptor T-Cell
26%
CAR T-cell therapy
23%
Solid Malignant Neoplasm
22%
Lung Cancer
21%
T-Helper Cell
20%
Programmed Death-Ligand 1
20%
T-Cell Response
20%
Receptor
19%
Mantle Cell Lymphoma
19%
Leukemia
19%
Acute Myeloid Leukemia
19%
Malignant Neoplasm
18%
Tumor Progression
17%
Immunosuppressive Treatment
16%
Cytotoxic T-Cell
16%
Chimeric Antigen Receptor
16%
Cell Therapy
15%
Cell Survival
15%
Osteoclastogenesis
15%
Mantle Cell Lymphoma Cell
15%
Osteoclast
14%
Bone Destruction
14%
Immunosuppressive Drug
14%
Bone Lesion
14%
Leukemia Cell
14%
Breast Cancer
14%
Cancer Cell
14%
In Vitro
13%
Innate Immunity
12%
Cancer
12%
Mitogen Activated Protein Kinase P38
12%
Tumor Immunity
11%
Cancer Growth
11%
Tumor Antigen
11%
T Lymphocyte Receptor
11%
Interleukin 9
11%
Cancer Immunotherapy
11%
Osteoblast
10%
